Armistice Capital, LLC Portfolio Holdings

Armistice Capital, LLC

  • $7.08 Billion
  • Q4 2024

Armistice Capital, LLC has filed its 13F form on February 14, 2025 for Q4 2024 where it was disclosed a total value porftolio of $7.08 Billion distributed in 232 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Ptc Therapeutics, Inc. with a value of $288M, Supernus Pharmaceuticals, Inc. with a value of $175M, Travere Therapeutics, Inc. with a value of $128M, Neurocrine Biosciences Inc with a value of $122M, and Incyte Corp with a value of $122M.

Examining the 13F form we can see an increase of $1.06B in the current position value, from $6.02B to 7.08B.

Armistice Capital, LLC is based out at New York, NY

Below you can find more details about Armistice Capital, LLC portfolio as well as his latest detailed transactions.

Portfolio value $7.08 Billion
ETFs: $2.97 Billion
Healthcare: $2.74 Billion
Consumer Cyclical: $455 Million
Consumer Defensive: $393 Million
Technology: $383 Million
Communication Services: $45.7 Million
Industrials: $34.5 Million
Basic Materials: $27.5 Million
Other: $24.9 Million

Stock Holdings Table Market Cap. of $50 Millions to $300 Millions

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$279M
$41.9 Million 0.59% of portfolio
9,468,000
Q4 2024 Added 15.46%
$163M
$30.6 Million 0.43% of portfolio
5,396,000
Q4 2024 Added 3.77%
$177M
$21.6 Million 0.31% of portfolio
9,200,000
Q4 2024 Added 33.88%
$170M
$20.4 Million 0.29% of portfolio
6,276,000
Q4 2024 Added 0.29%
$203M
$13.9 Million 0.2% of portfolio
3,736,000
Q4 2024 Added 0.21%
$66.6M
$3.6 Million 0.05% of portfolio
6,800,000
Q3 2024 Reduced 23.9%
$194M
$2.6 Million 0.04% of portfolio
4,006,784
Q4 2024 Reduced 19.54%
$197M
$2.45 Million 0.03% of portfolio
1,236,000
Q4 2024 Added 147.2%
$150M
$1.67 Million 0.02% of portfolio
300,000
Q4 2024 Reduced 10.71%
$59.7M
$1.6 Million 0.02% of portfolio
4,315,000
Q4 2024 New
$174M
$952,000 0.01% of portfolio
1,024,000
Q4 2024 Added 2.4%

Summary

  • Portfolio
  • No. of Stocks 232
  • Current Value $7.08 Billion
  • Prior Value $6.02 Billion
  • Filing
  • Period Q4 2024
  • Filing Date February 14, 2025
  • Form Type 13F-HR
  • Activity in Q4 2024
  • New Purchases 63 stocks
  • Additional Purchases 77 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 60 stocks
Track This Portfolio

Track Armistice Capital, LLC Portfolio

Follow Armistice Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Armistice Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Armistice Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email